ArticleInternational journal of immunopathology and pharmacology

HLA-A2.1-restricted T cells react to SEREX-defined tumor antigen CML66L and are suppressed by CD4+CD25+ regulatory T cells.

Y Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.